President Trump aims to enhance American health and economic growth, relying significantly on the National Institutes of Health (NIH). However, the administration's recent freeze on NIH meetings for new grants and proposed funding caps have alarming effects, leading research universities to cut studies and rescind doctorate offers. The NIH functions similarly to a venture capital firm, yielding significant societal returns on invested funds. Despite increased funding for research institutions from 2019 to 2023, the NIH's ability to stimulate innovation may be jeopardized by potential budget constraints.
President Trump emphasizes the need to restore America's health and economic growth, heavily relying on the NIH despite recent funding challenges.
The NIH is like a venture capital firm for science, yielding $0.43 in societal returns for every $1 invested in basic research.
The Trump administration has paused NIH meetings on new grants, causing research institutions to cut studies and rescind doctoral offers.
NIH's substantial budget helps support innovation across universities and research hospitals, yet funding cuts could stifle important studies and advancements.
Collection
[
|
...
]